Nastasya Nunki

Nastasya Nunki

Auto-generated profile, based on publicly available information

Nastasya Nunki

Laboratory Medicine, Master Program of Basic Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2024 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
NNNastasya Nunki
Nastasya Nunki
YHYetti Hernaningsih
Yetti Hernaningsih
PWPuspa Wardhani
Puspa Wardhani
AHAsih Herawati
Asih Herawati
NYNarazah Mohd Yusoff
Narazah Mohd Yusoff
BSBambang Pujo Semedi
Bambang Pujo Semedi
Nastasya Nunki, M.S., Yetti Hernaningsih, M.D., Ph.D., Puspa Wardhani, M.D., Ph.D., Asih Herawati, M.D., Narazah Mohd Yusoff, MBBS., Ph.D., Emmanuel Jairaj Moses, Ph.D., and Bambang Pujo Semedi, M.D., Ph.D.. Ann Lab Med -0001;0:. https://doi.org/10.3343/alm.2023.0395

6 June 2024 in INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
Verified
Journal Article
Open access
PDF file
Arifa MustikaArifa Mustika
Arifa Mustika
YHYetti Hernaningsih
Yetti Hernaningsih
PWPuspa Wardhani
Puspa Wardhani
Siti KhaerunnisaSiti Khaerunnisa
Siti Khaerunnisa
NNNastasya Nunki
Nastasya Nunki
DSDesty Indah Sari
Desty Indah Sari
Degenerative diseases arise when age increases due to the weakening of the body's physiological condition. The purpose of this study was to measure glucose, uric acid, and cholesterol levels in residents of Segunung Village to improve lifestyles and quality of life. As many as 110 residents of Segunung Village were used as subjects in this cross-sectional study. Glucose, uric acid, and cholesterol levels were measured using Point of Care Testing (POCT). A cut-off value of <200 was used to define high cholesterol levels. Only cholesterol levels showed an increase when compared with reference values, while glucose and uric acid levels were normal. Interestingly glucose was significantly correlated with age (r=0.309, p=0.001). The approach using POCT describes the overall condition of Segunung villagers and can be used as a basis for glucose, uric acid, and cholesterol screening tests.

15 June 2025 in INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
Verified
Journal Article
Open access
PDF file
YHYetti Hernaningsih
Yetti Hernaningsih
AAAryati Aryati
Aryati Aryati
IUI Dewa Gede Ugrasena
I Dewa Gede Ugrasena
NNNastasya Nunki
Nastasya Nunki
Uncontrolled proliferation and resistance to apoptosis should be controlled to kill the cancer cells, as the goal of treatment in acute leukemia. It is therefore important to know, which characteristic dominates the proliferative phase because, to be more effective, new drugs that will be developed should be targeted at that phase. This study aimed to find the dominant phase in the proliferative phase of the cell cycle in childhood Acute Lymphoblastic Leukemia (ALL). This study was conducted on 63 patients, comprising 33 patients with specimens of Bone Marrow Mononuclear Cells (BMMC), 30 patients with specimens of Peripheral Blood Mononuclear Cells (PBMC), and 10 children as controls with specimens of PBMC. Cell cycle examinations were performed with PI/RNase, run on BD FACS Calibur, and analyzed with modfit LT 4.1 software to determine the phases of G0/G1, synthesis (S), and mitosis (G2/M). Regarded the S and G2/M phases as the proliferation phase. Statistical analyses used one-way ANOVA and Kruskal-Wallis to compare S and G2/M phases within groups,and an Independent T-test and Mann-Whitney to compare the same phases between groups. Among the proliferation phases, the synthesis phase had significantly higher domination than the mitotic phase in both the BMMC (10.18±7.81% vs. 5.41±3.77%; p = 0.010) and PBMC (4.33±2.15% vs 2.30±1.56%; p=0.000) groups. A similar result was found in the control group (1.01±0.51% vs 0.36±0.38%; p=0.011). The synthesis phase in BMMC had significantly higher domination than PBMC groups (p=0.024) and control (p 0.002). The synthesis phase predominates among the proliferation phases of the cell cycle in childhood ALL.

20 October 2025 in INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
Verified
Journal Article
Open access
PDF file
YHYetti Hernaningsih
Yetti Hernaningsih
ACAndi Cahyadi
Andi Cahyadi
RRRahmi Rusanti
Rahmi Rusanti
EAErawati Armayani
Erawati Armayani
SJSyntia Tanu Juwita
Syntia Tanu Juwita
NNNastasya Nunki
Nastasya Nunki
The proliferation and apoptosis assays have been utilized in numerous studies to develop new substances such as antineoplastic agents. Commonly, it was performed in ex-vivo conditions using the culture method. However, the cytotoxic or cytostatic effects observed ex vivo often differ from those in vivo. This study investigated differences in proliferation and apoptosis of lymphoblast between in vivo and ex vivo conditions of childhood ALL. This study was conducted on new childhood acute lymphoblastic leukemia (ALL) patients. Nineteen (19) subjects were recruited, comprising of 10 with favorable and 9 with unfavorable outcomes. The negative control came from 8 healthy children volunteers. All patients under went leukemia immunophenotyping, including CD34, to identify the phenotype. Bone marrow mononuclear cells (BMMCs) of patient groups were analyzed using apoptosis and proliferation assays, as well as the negative control group, and then compared to the in vivo condition. 12 out of 19 BMMC were cultured for 48 hours, and proliferation and apoptosis assays were performed in ex vivo conditions. The results showed that the proliferation, apoptosis, and apoptosis/proliferation (A/P) ratio of the patients in the ex vivo group were significantly higher than the in vivo group with p =0.000, p =0.050, and p =0.000, respectively. The proliferation was higher for patient groups than the control group, with p =0.001 and p =0.004, respectively. The apoptosis rates of the patient group were higher than the control group, with p =0.000 and p =0.002, respectively. The proliferation and apoptosis of lymphoblasts ex vivo are higher than in vivo.

5 May 2026 in Journal of Associated Medical Sciences
Verified
Journal Article
Open access
PDF file
NNNastasya Nunki
Nastasya Nunki
YHYetti Hernaningsih
Yetti Hernaningsih
PWPuspa Wardhani
Puspa Wardhani
CWCitrawati Wungu
Citrawati Wungu
ASAgil Saputra
Agil Saputra
NYNarazah Mohd Yusoff
Narazah Mohd Yusoff
Background: Elevated microvesicle (MV) levels are potential biomarkers of coronavirus disease 2019 (COVID-19). We compared different types of microvesicles (total microvesicles, TMVs), platelet-derived microvesicles (PMVs), endothelium-derived microvesicles (EMVs), and tissue factor-bearing microvesicles (TF-MVs). Objectives: We investigated the correlations between microvesicles and D-dimers, as well as between microvesicles and COVID-19 severity. Materials and methods: A systematic literature search was conducted in PubMed, Web of Science, Scopus, and ScienceDirect to identify relevant studies comparing microvesicle types between patients with COVID-19 and healthy controls. Pooled estimates of the standardized mean difference (SMD) for each MV type were calculated using RevMan 5.4, along with the corresponding 95% confidence intervals (CIs). Results: This meta-analysis included six studies comprising 183 COVID-19 patients and 135 healthy controls for quantitative analysis. Compared with controls, COVID-19 patients presented significantly higher levels of circulating TMVs, PMVs, EMVs, and TF-MVs (TMVs: SMD=4.27, 95% CI 2.18-6.36, p<0.0001; PMVs: SMD=2.07, 95% CI 0.99-3.15, p=0.0002; EMVs: SMD=1.20, 95% CI 0.56-1.84, p=0.0002; and TF-MVs: SMD=2.56, 95% CI 1.98-3.15, p<0.00001). D-dimer levels were correlated with MV levels (N=82, r=0.430, 95% CI 0.227-0.592, p<0.0001). In general, MVs were correlated with COVID-19 severity (N=168; r=0.942; 95% CI, 0.558-0.993; p=0.002). Conclusion: Patients with severe COVID-19 had elevated levels of TMVs, PMVs, EMVs, and TF-MVs. Therefore, MVs may contribute to the procoagulant effects associated with prognostic and severity biomarkers of COVID-19.